Search results
Novavax (NVAX) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
Zacks via Yahoo Finance· 14 hours agoNovavax (NVAX) possesses the right combination of the two key ingredients for a likely earnings beat...
Novavax to Host Conference Call to Discuss First Quarter 2024 Financial Results and Operational...
WKRN Nashville· 14 hours agoNovavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its Matrix-M™ adjuvant, today announced it will report its first quarter 2024 financial ...
Shah Capital seeks board overhaul at Novavax By Investing.com
Investing.com· 1 day agoShah Capital Management, a major shareholder in Novavax Inc. (NASDAQ:NVAX), has publicly expressed...
Shah Capital urges Novavax shareholders to vote against three directors
Reuters via AOL· 2 days ago(Reuters) -Hedge fund Shah Capital on Monday urged Novavax shareholders to vote against the...
Novavax’s top shareholder Shah Capital ramps up efforts for board shakeup
WHTC 1450 Holland· 2 days ago(Reuters) - Hedge fund Shah Capital on Monday urged Novavax shareholders to vote against the...
Novavax, Inc. (NASDAQ:NVAX) Shares Sold by Federated Hermes Inc.
ETF DAILY NEWS· 2 days agoFederated Hermes Inc. lowered its position in shares of Novavax, Inc. (NASDAQ:NVAX – Free Report) by 88.6% in the fourth quarter, according to the company in its most recent ...
What to know about the new 'FLiRT' COVID variants that are spreading: Your guide to the latest virus...
Yahoo Life· 1 day agoHere’s your go-to guide with everything you need to know about COVID-19, including the latest...
Novavax investor Shah Capital to vote against three directors
Reuters via Yahoo Finance· 2 days agoMay 6 (Reuters) - Hedge fund Shah Capital said on Monday that it intends to vote against election of three directors on the board of COVID-19 vaccine maker Novavax. Shah Capital ...
Flu vs COVID: Stark Disparity in Vaccination and Deaths
Medscape· 6 days agoIn the first half of 2023, COVID-19 killed 42,670 people in the United States, while the flu killed...
Is Moderna Stock A Buy On Its Eye-Popping First-Quarter Sales Beat?
Investor's Business Daily· 5 days agoThe company noted that it achieved 48% market share for Covid vaccines in the U.S. during the fall...